Parkinsonโ€™s disease Prevalence Study

New Parkinsonโ€™s disease prevalence study Trying to estimate the number of people living with Parkinsonโ€™s disease (PD) in North...see more America is extremely important but notoriously difficult. It is critical to know the prevalence of PD because it informs lawmakers who make decisions concerning allocation of research funds about the true impact of the disease, and […]

Read More

Deep Brain Stimulation May Slow Tremor Progression

Deep brain stimulation may slow the progression of tremor if performed in early Parkinsonโ€™s disease. APDA funding is helping...see more further the efforts to find out more. New results, published in the June 29, 2018, online issue of Neurology suggest that deep brain stimulation (DBS) may slow the progression of tremor if performed early on in […]

Read More

Ask the Doctor

Dr. Terry Ellis, Assistant Professor at Boston University College of Health & Rehabilitation Sciences, Director of...see more the Center for Neurorehabilitation, Advisor for the APDA Massachusetts Chapter. Q. What is the best kind of exercise for Parkinsonโ€™s? A. There are several types of exercise that are important for people with Parkinsonโ€™s disease. Aerobic […]

Read More

New Information & Referral Centers Support PD Communities Nationwide

New Information & Referral Centers Support PD Communities Nationwide APDA is thrilled to announce the opening of three new...see more Information & Referral (I&R) Centers across the country! In San Francisco, CA; Vernon, CT, and Chicago, IL, we are expanding the reach of our vital services to people with Parkinsonโ€™s disease (PD) and their care partners. […]

Read More

APDA SCIENTIFIC ADVISORY BOARD EVALUATES EXCITING RESEARCH IDEAS FOR 2018-2019 RESEARCH FUNDING

Established and Up-and-Coming Researchers Vie for More Than $1,700,000 in Funding NEW YORK, NY, May 24, 2018 โ€“ The...see more American Parkinson Disease Associationโ€™s (APDA) Scientific Advisory Board recently met to review 70 grant submissions all vying for funding to be awarded in the field of Parkinsonโ€™s research. In addition, the Scientific Advisory Board (SAB) reviewed […]

Read More

APDA Updates Regarding PD Psychosis Treatment

On April 9, 2018, CNN published an article on the drug, Nuplazid, the only FDA-approved medication for the treatment...see more of Parkinsonโ€™s disease psychosis. The American Parkinson Disease Association (APDA) recommends that patients discuss with their neurologists any concerns about the drug that the article may have raised. The FDA continues to monitor safety of this […]

Read More